Rapid Fire: Hypercalcemia

被引:9
作者
Carrick, Angela Irene [1 ]
Costner, Holly Briann [1 ]
机构
[1] Norman Reg Hosp, Emergency Med Residency, 901 North Porter, Norman, OK 73071 USA
关键词
Hypercalcemia; Malignancy; Endocrine; Treatment; Emergency medicine; Metabolic emergency;
D O I
10.1016/j.emc.2018.04.008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Hypercalcemia is commonly encountered in the clinical setting and requires identification by the clinician to avoid disastrous patient outcomes. The 2 most common causes are malignancy and hyperparathyroidism. The underlying cause for hypercalcemia may be readily known at presentation or may require further investigation. After identification, acuity of treatment will depend on the severity of calcium level and symptoms. In the emergency setting, intravenous hydration with isotonic fluids is the treatment mainstay. Other commonly used medications to further decrease calcium include bisphosphates, calcitonin, steroids, and (rarely) furosemide. In life-threatening circumstances, dialysis can be implemented.
引用
收藏
页码:549 / +
页数:8
相关论文
共 6 条
[1]  
Durant E, 2017, AM J EMERG MED, V35
[2]  
Goldner W, 2016, J ONCOL PRACT, V12, P1277, DOI [10.1200/JOP.2016.017335, 10.1200/JOP.2016.011155]
[3]   Hypercalcemia in the Intensive Care Unit: A Review of Pathophysiology, Diagnosis, and Modern Therapy [J].
Maier, Joshua D. ;
Levine, Steven N. .
JOURNAL OF INTENSIVE CARE MEDICINE, 2015, 30 (05) :235-252
[4]  
Malangone Steve, 2015, J Adv Pract Oncol, V6, P586
[5]  
Naganathan S, 2017, HYPERCALCEMIA STATPE
[6]   Hypercalcaemia - presentation and management [J].
Turner, Jeremy J. O. .
CLINICAL MEDICINE, 2017, 17 (03) :270-273